Federal Register / Vol. 73, No. 150 / Monday, August 4, 2008 / Notices 45227 

will be collected in 6 community mental 

health sites. This project will collect 

data from clients using a brief survey 

administered on a voluntary basis. 

Collection of data will provide 

information on client demographics; 

current behaviors that may facilitate 

HIV transmission, including sexual and 

drug-use behaviors; current psychiatric 

symptoms, determined using brief rating 

scales; access and barriers to HIV 

testing, prevention, and treatment 

services; and adherence to psychiatric 

and medical treatment regimens. 

CDC estimates the response rate will 

be approximately 90%. Of the 644 

persons approached who agree to be 

surveyed, it is estimated that 95% of 

persons will meet the eligibility criteria 

and 98% will be able to provide 

informed consent. Therefore, the goal 

will be to approach 716 persons 

annually for participation in the study. 

The structured interview will take 

approximately 20 minutes to complete. 

Participation is voluntary. Data 

collection will provide important 

insights into the relationship between 

HIV/STI risk behaviors and psychiatric 

illness. 

There is no cost to the respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name No. of respondents 

No. of responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden hours 

Approached Individual .............................. Eligibility Screener .................................... 644 1 1/60 11 

Eligible participant ..................................... Consent Questionnaire ............................. 612 1 10/60 102 

Consented participant ............................... Core Questionnaire .................................. 600 1 20/60 200 

Total ................................................... ................................................................... .................... .................... .................... 313 

Marilyn S. Radke, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E8–17775 Filed 8–1–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Notice of Public Comment on Tribal 

Consultation Session To Be Held on 

September 11, 2008, in Phoenix, AZ 

AGENCY: Office of Head Start (OHS). 

ACTION: Notice of Public Comment on 

Tribal Consultation Session to be held 

on September 11, 2008, in Phoenix, 

Arizona. 

SUMMARY: Pursuant to the Improving 

Head Start for School Readiness Act of 

2007, Public Law 110–134, notice is 

hereby given of a one-day Tribal 

Consultation Session to be held between 

the Department of Health and Human 

Services, Administration for Children 

and Families, Office of Head Start 

leadership and the leadership of Tribal 

governments operating Head Start 

(including Early Head Start) programs. 

The purpose of the Consultation Session 

is to discuss ways to better meet the 

needs of Indian, including Alaska 

Native, children and their families, 

taking into consideration funding 

allocations, distribution formulas, and 

other issues affecting the delivery of 

Head Start services in their geographic 

locations [42 U.S.C. 9835, Section 

640(l)(4)]. 

Date & Location: The Consultation 

Session will be held on September 11, 

2008, at the Hyatt Regency Phoenix in 

Phoenix, Arizona. 

FOR FURTHER INFORMATION CONTACT: 

Rene ́e Perthuis, Acting Regional 

Program Manager, American Indian/ 

Alaska Native Program Branch, Office of 

Head Start, e-mail 

reneeaian@acf.hhs.gov or (202) 260–

1721. Register to attend the Consultation 

Session online at www.hsnrc.org. 

SUPPLEMENTARY INFORMATION: The 

Department of Health and Human 

Services would like to invite leaders of 

Tribal governments operating Head Start 

(including Early Head Start) programs to 

participate in a formal Consultation 

Session with OHS leadership. The 

Consultation Session will take place on 

Thursday, September 11, 2008, at the 

Hyatt Regency Phoenix in Phoenix, 

Arizona. 

The purpose of the Consultation 

Session is to solicit input on ways to 

better meet the needs of Indian, 

including Alaska Native, children and 

their families, taking into consideration 

funding allocations, distribution 

formulas, and other issues affecting the 

delivery of Head Start services in their 

geographic locations. Specific topics 

will include policy, research, Head 

Start/Early Head Start conversion, 

program quality, and monitoring. 

Tribal leaders and designated 

representatives interested in submitting 

written testimony or topics for the 

Consultation Session agenda should 

contact Rene ́e Perthuis at 

reneeaian@acf.hhs.gov. The proposal 

agenda topics should include a brief 

description of the topic area along with 

the name and contact information of the 

suggested presenter. 

The Consultation Session will be 

conducted with elected or appointed 

leaders of Tribal governments and their 

designated representatives [42 U.S.C. 

9835, Section 640(l)(4)(A)]. 

Representatives from Tribal 

organizations and Native non-profit 

organizations are welcome to attend as 

observers. Those wishing to participate 

in the discussions must have a copy of 

a letter signed by an elected or 

appointed official or their designee, 

which authorizes them to serve as a 

representative of the Tribe. This should 

be submitted not less than three days in 

advance of the Consultation Session to 

Rene ́e Perthuis at 202–205–9721 (fax). 

A detailed report of the Consultation 

Session will be prepared and made 

available within 90 days of the 

consultation to all Tribal governments 

receiving funds for Head Start 

(including Early Head Start) programs. 

Dated: July 29, 2008. 

Patricia Brown, 

Acting Director, Office of Head Start. 

[FR Doc. E8–17774 Filed 8–1–08; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–D–0387] 

Draft Guidance for Industry on 

Labeling OTC Skin Protectant Drug 

Products; Availability 

AGENCY: Food and Drug Administration, 

HHS. 


pwalker on PROD1PC71 with NOTICES